Acuta Capital Partners as of June 30, 2025
Portfolio Holdings for Acuta Capital Partners
Acuta Capital Partners holds 28 positions in its portfolio as reported in the June 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ocular Therapeutix (OCUL) | 13.1 | $9.4M | 1.0M | 9.28 | |
| Cidara Therapeutics Com New (CDTX) | 12.2 | $8.7M | 180k | 48.71 | |
| Aadi Bioscience (WHWK) | 8.9 | $6.4M | 3.4M | 1.87 | |
| Soleno Therapeutics (SLNO) | 7.4 | $5.3M | 63k | 83.78 | |
| Tourmaline Bio (TRML) | 6.3 | $4.5M | 284k | 15.99 | |
| Ascendis Pha- Sponsored Adr (ASND) | 5.4 | $3.9M | 23k | 172.60 | |
| Insmed Com Par $.01 (INSM) | 5.2 | $3.7M | 37k | 100.64 | |
| Argen Se - Sponsored Adr (ARGX) | 5.2 | $3.7M | 6.7k | 551.22 | |
| Praxis Precision Medicines I (PRAX) | 4.3 | $3.1M | 74k | 42.05 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 3.9 | $2.8M | 26k | 106.12 | |
| Trevi Therapeutics (TRVI) | 3.8 | $2.7M | 494k | 5.47 | |
| Oculis Holding Ordinary Shares (OCS) | 2.9 | $2.1M | 107k | 19.41 | |
| Revolution Medicines (RVMD) | 2.9 | $2.0M | 56k | 36.79 | |
| Helix Acquisition Corp Ii Cl A Ord Shs (HLXB) | 2.8 | $2.0M | 187k | 10.62 | |
| Terns Pharmaceuticals (TERN) | 2.4 | $1.7M | 464k | 3.73 | |
| Surrozen Com New (SRZN) | 2.1 | $1.5M | 170k | 8.94 | |
| Bright Minds Biosciences Com New (DRUG) | 1.8 | $1.3M | 49k | 26.11 | |
| Taysha Gene Therapies Com Shs (TSHA) | 1.6 | $1.1M | 486k | 2.31 | |
| Akero Therapeutics (AKRO) | 1.5 | $1.1M | 20k | 53.36 | |
| Zymeworks Del (ZYME) | 1.5 | $1.0M | 84k | 12.55 | |
| Liquidia Corporation Com New (LQDA) | 1.3 | $945k | 76k | 12.46 | |
| Ultragenyx Pharmaceutical (RARE) | 1.2 | $866k | 24k | 36.36 | |
| Verastem Com New (VSTM) | 0.9 | $624k | 150k | 4.15 | |
| Fulcrum Therapeutics (FULC) | 0.6 | $410k | 60k | 6.88 | |
| Unicycive Therapeutics (UNCY) | 0.4 | $300k | 63k | 4.77 | |
| Rapport Therapeutics (RAPP) | 0.3 | $227k | 20k | 11.37 | |
| Artiva Biotherapeutics (ARTV) | 0.1 | $69k | 46k | 1.51 | |
| Nuvation Bio Inc -cw27 *w Exp 07/07/2027 (NUVB.WS) | 0.0 | $25k | 91k | 0.27 |
